Business:
Radiopharmaceuticals
Drug notes:
5+ additional undisclosed programs RD/Clin0 multiple cancers, undisclosed
About:
Alpha-9 Theranostics is a clinical stage company developing highly selective, peptide-based radiopharmaceuticals for cancer treatment. Their treatments are developed with a binder, linker, chelator, and radioisotope, giving them high selectivity for delivering radiation to cancer cells with minimal off-target effects. Their developed molecules are optimized for imaging, dosimetry, and therapy studies to evaluate the tumor uptake and dose delivery, as well as determine the optimal patient population. Alpha-9 Theranostics was founded in 2019 by researchers in British Columbia to improve the lives of people with metastatic cancers. Alpha-9 Theranostics’ new research facility in Vancouver was completed in 2023, housing chemistry, biology, and radiochemistry R&D teams to accelerate their discovery efforts.
Scientist I, Radiochemistry Vancouver, British Columbia, Canada|6 days ago
Scientist I, Tx Radiochemistry CMC Vancouver, British Columbia, Canada|21 days ago
Associate Scientist II, in vivo Pharmacology Vancouver, British Columbia, Canada|25 days ago
Assistant Controller/Controller Boston, MA|28 days ago
Principal Scientist Dx CMC Radiochemistry Vancouver, British Columbia, Canada|65 days ago
Safety Manager Vancouver, British Columbia, Canada|66 days ago
Principal Scientist/Associate Director, Translatio... Vancouver, British Columbia, Canada|66 days ago
Associate Director, Intellectual Property Boston, MA|Not provided